
PMC:7050114 / 8364-9124
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
123 | 281-284 | Gene | denotes | TDF | Gene:6736 |
124 | 421-425 | Species | denotes | Lian | Tax:155640 |
125 | 77-96 | Chemical | denotes | Lopinavir/Ritonavir | MESH:C558899 |
126 | 182-192 | Chemical | denotes | Remdesivir | MESH:C000606551 |
127 | 605-626 | Chemical | denotes | chloroquine phosphate | MESH:C023676 |
128 | 54-62 | Disease | denotes | COVID-19 | MESH:C000657245 |
129 | 488-496 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T61 | 10-15 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
T60 | 54-62 | SP_7 | denotes | COVID-19 |
T58 | 87-96 | DG_30 | denotes | Ritonavir |
T57 | 98-108 | CHEBI:60783;CHEBI:60783 | denotes | Nucleoside |
T56 | 125-134 | DG_29 | denotes | ribavirin |
T55 | 151-161 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
T54 | 168-179 | CHEBI:7798;CHEBI:7798 | denotes | oseltamivir |
T53 | 182-192 | DG_28 | denotes | Remdesivir |
T52 | 201-214 | CHEBI:36807;CHEBI:36807 | denotes | hydrochloride |
T51 | 216-229 | GO:0032774 | denotes | RNA synthesis |
T50 | 230-240 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
T49 | 250-279 | CHEBI:63718;CHEBI:63718 | denotes | Tenofovir disoproxil fumarate |
T48 | 287-310 | CHEBI:35472;CHEBI:35472 | denotes | anti-inflammatory drugs |
T47 | 339-348 | CHEBI:36357;CHEBI:36357 | denotes | molecules |
T46 | 488-496 | SP_7 | denotes | COVID-19 |
T45 | 537-542 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
T44 | 605-616 | CHEBI:3638;DG_10;CHEBI:3638 | denotes | chloroquine |
T43 | 617-626 | CHEBI:18367;CHEBI:18367 | denotes | phosphate |
T42 | 685-693 | CHEBI:75958;CHEBI:75958 | denotes | solution |
T59 | 77-86 | DG_23 | denotes | Lopinavir |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T6 | 216-219 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T7 | 320-328 | Body_part | denotes | hormones | http://purl.org/sig/ont/fma/fma12278 |
T8 | 408-416 | Body_part | denotes | Capsules | http://purl.org/sig/ont/fma/fma85272 |
T9 | 439-446 | Body_part | denotes | Capsule | http://purl.org/sig/ont/fma/fma85272 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T6 | 439-446 | Body_part | denotes | Capsule | http://purl.obolibrary.org/obo/UBERON_0003893 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T27 | 54-62 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T28 | 488-496 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T43 | 627-630 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T2 | 10-15 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T3 | 77-86 | Chemical | denotes | Lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
T4 | 98-108 | Chemical | denotes | Nucleoside | http://purl.obolibrary.org/obo/CHEBI_33838 |
T5 | 125-134 | Chemical | denotes | ribavirin | http://purl.obolibrary.org/obo/CHEBI_63580 |
T6 | 137-161 | Chemical | denotes | Neuraminidase inhibitors | http://purl.obolibrary.org/obo/CHEBI_52425 |
T7 | 151-161 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T8 | 168-179 | Chemical | denotes | oseltamivir | http://purl.obolibrary.org/obo/CHEBI_7798 |
T9 | 201-214 | Chemical | denotes | hydrochloride | http://purl.obolibrary.org/obo/CHEBI_36807 |
T10 | 230-240 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T11 | 250-279 | Chemical | denotes | Tenofovir disoproxil fumarate | http://purl.obolibrary.org/obo/CHEBI_63718 |
T12 | 271-279 | Chemical | denotes | fumarate | http://purl.obolibrary.org/obo/CHEBI_29806 |
T13 | 281-284 | Chemical | denotes | TDF | http://purl.obolibrary.org/obo/CHEBI_63718 |
T14 | 287-310 | Chemical | denotes | anti-inflammatory drugs | http://purl.obolibrary.org/obo/CHEBI_35472 |
T15 | 305-310 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T16 | 320-328 | Chemical | denotes | hormones | http://purl.obolibrary.org/obo/CHEBI_24621 |
T17 | 339-348 | Chemical | denotes | molecules | http://purl.obolibrary.org/obo/CHEBI_25367 |
T18 | 381-384 | Chemical | denotes | TCM | http://purl.obolibrary.org/obo/CHEBI_145500 |
T19 | 537-542 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T20 | 605-616 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
T21 | 617-626 | Chemical | denotes | phosphate | http://purl.obolibrary.org/obo/CHEBI_18367|http://purl.obolibrary.org/obo/CHEBI_26020|http://purl.obolibrary.org/obo/CHEBI_35780|http://purl.obolibrary.org/obo/CHEBI_43474 |
T25 | 685-693 | Chemical | denotes | solution | http://purl.obolibrary.org/obo/CHEBI_75958 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 216-229 | http://purl.obolibrary.org/obo/GO_0032774 | denotes | RNA synthesis |
T5 | 220-229 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | synthesis |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T65 | 0-63 | Sentence | denotes | Effective drugs have yet to be developed to treat the COVID-19. |
T66 | 64-595 | Sentence | denotes | Temporarily, Lopinavir/Ritonavir, Nucleoside analogues (e.g. ribavirin), Neuraminidase inhibitors (e.g. oseltamivir), Remdesivir, abidol hydrochloride, RNA synthesis inhibitors (such as Tenofovir disoproxil fumarate, TDF), anti-inflammatory drugs (such as hormones and other molecules), Traditional Chinese Medicine (TCM), such Shu Feng Jie Du Capsules and Lian Hua Qing Wen Capsule, are being used as treatment options for COVID-19, but their efficacy and safety of these drugs are yet to be clinically observed in treatments [9]. |
T67 | 596-760 | Sentence | denotes | Besides, chloroquine phosphate has recently been recommended by the clinical diagnostics solution (6th edition) released by the National Health Commission of China. |